Emerging Anti-cancer Targets in Mitochondria
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985823%3A_____%2F14%3A00432135" target="_blank" >RIV/67985823:_____/14:00432135 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1007/978-94-017-8984-4_10" target="_blank" >http://dx.doi.org/10.1007/978-94-017-8984-4_10</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/978-94-017-8984-4_10" target="_blank" >10.1007/978-94-017-8984-4_10</a>
Alternative languages
Result language
angličtina
Original language name
Emerging Anti-cancer Targets in Mitochondria
Original language description
Extensive review of potential targets for anti-cancer treatment focusing on mitochondrial metabolism. Those targets include the mitochondrial isocitrate dehydrogenase-2 (IDH2), hexokinase-2 (HK2), and cancer?specific isoforms of pyruvate dehydrogenase kinase
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GPP301%2F12%2FP381" target="_blank" >GPP301/12/P381: The role of mitochondrial IDH2 in bioenergetics, redox regulations, and cancer</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Mitochondria: The Anti- cancer Target for the Third Millennium
ISBN
978-94-017-8983-7
Number of pages of the result
26
Pages from-to
265-290
Number of pages of the book
382
Publisher name
Springer
Place of publication
Dordrecht
UT code for WoS chapter
—